A detailed history of Edge Wealth Management LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Edge Wealth Management LLC holds 90,228 shares of ROIV stock, worth $1.15 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
90,228
Previous 90,228 -0.0%
Holding current value
$1.15 Million
Previous $953,000 9.23%
% of portfolio
0.21%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$9.87 - $11.8 $91,791 - $109,740
-9,300 Reduced 9.34%
90,228 $951,000
Q4 2023

Jan 11, 2024

SELL
$8.38 - $11.58 $293,300 - $405,300
-35,000 Reduced 26.02%
99,528 $1.12 Million
Q3 2023

Oct 13, 2023

SELL
$9.76 - $13.19 $400,199 - $540,842
-41,004 Reduced 23.36%
134,528 $1.57 Million
Q2 2023

Jul 13, 2023

SELL
$7.09 - $10.08 $655,825 - $932,400
-92,500 Reduced 34.51%
175,532 $1.77 Million
Q3 2022

Oct 18, 2022

BUY
$0.51 - $4.84 $136,696 - $1.3 Million
268,032 New
268,032 $871,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.95B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Edge Wealth Management LLC Portfolio

Follow Edge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Wealth Management LLC with notifications on news.